{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:36:40Z","timestamp":1791607000609,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2020622"],"award-info":[{"award-number":["BE2020622"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172639, 81972388"],"award-info":[{"award-number":["82172639, 81972388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Key Medical Discipline","award":["ZDXKB2016014"],"award-info":[{"award-number":["ZDXKB2016014"]}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["QRX17128"],"award-info":[{"award-number":["QRX17128"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19283-1","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:36:14Z","timestamp":1760016974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The expression of prostate-specific membrane antigen in intraductal carcinoma of the prostate"],"prefix":"10.1038","volume":"15","author":[{"given":"Zheng","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"19283_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"Cancer J. Clin."},{"key":"19283_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/pros.23818","volume":"79","author":"M Kato","year":"2019","unstructured":"Kato, M. et al. The influence of the presence of intraductal carcinoma of the prostate on the grade group system\u2019s prognostic performance. Prostate 79, 1065\u20131070 (2019).","journal-title":"Prostate"},{"key":"19283_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.eururo.2017.03.013","volume":"72","author":"LH Porter","year":"2017","unstructured":"Porter, L. H. et al. Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories. Eur. Urol. 72, 492\u2013495 (2017).","journal-title":"Eur. Urol."},{"key":"19283_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.urolonc.2017.08.015","volume":"35","author":"BF Dinerman","year":"2017","unstructured":"Dinerman, B. F. et al. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol. Oncol. 35, 673 (2017). .e679-673.e614.","journal-title":"Urol. Oncol."},{"key":"19283_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.humpath.2014.03.011","volume":"45","author":"K Miyai","year":"2014","unstructured":"Miyai, K. et al. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion. Hum. Pathol. 45, 1572\u20131581 (2014).","journal-title":"Hum. Pathol."},{"key":"19283_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ejca.2012.02.003","volume":"48","author":"T Van der Kwast","year":"2012","unstructured":"Van der Kwast, T. et al. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur. J. Cancer (Oxford England: 1990). 48, 1318\u20131325 (2012).","journal-title":"Eur. J. Cancer (Oxford England: 1990)"},{"key":"19283_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/pros.23326","volume":"77","author":"T Saeter","year":"2017","unstructured":"Saeter, T. et al. Intraductal carcinoma of the prostate on diagnostic needle biopsy predicts prostate cancer mortality: A Population-Based study. Prostate 77, 859\u2013865 (2017).","journal-title":"Prostate"},{"key":"19283_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/pros.22906","volume":"75","author":"T Zhao","year":"2015","unstructured":"Zhao, T. et al. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer? Prostate 75, 225\u2013232 (2015).","journal-title":"Prostate"},{"key":"19283_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/bju.14043","volume":"121","author":"LH Porter","year":"2018","unstructured":"Porter, L. H. et al. Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells. BJU Int. 121, 971\u2013978 (2018).","journal-title":"BJU Int."},{"key":"19283_CR10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/pros.23005","volume":"75","author":"Z Chen","year":"2015","unstructured":"Chen, Z. et al. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer. Prostate 75, 1247\u20131254 (2015).","journal-title":"Prostate"},{"key":"19283_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/PAI.0000000000000110","volume":"23","author":"MC Tsourlakis","year":"2015","unstructured":"Tsourlakis, M. C. et al. PSMA expression is highly homogenous in primary prostate cancer. Appl. Immunohistochem. Mol. Morphology: AIMM. 23, 449\u2013455 (2015).","journal-title":"Appl. Immunohistochem. Mol. Morphology: AIMM"},{"key":"19283_CR12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman, M. S. et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet (London England). 395, 1208\u20131216 (2020).","journal-title":"Lancet (London England)"},{"key":"19283_CR13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","volume":"5","author":"WP Fendler","year":"2019","unstructured":"Fendler, W. P. et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: A prospective Single-Arm clinical trial. JAMA Oncol. 5, 856\u2013863 (2019).","journal-title":"JAMA Oncol."},{"key":"19283_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.euf.2020.03.004","volume":"7","author":"E Lopci","year":"2021","unstructured":"Lopci, E. et al. Prospective evaluation of (68)Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography in primary prostate cancer diagnosis. Eur. Urol. Focus. 7, 764\u2013771 (2021).","journal-title":"Eur. Urol. Focus"},{"key":"19283_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.118.221010","volume":"60","author":"M Chen","year":"2019","unstructured":"Chen, M. et al. Combination of (68)Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: A Lesion-by-Lesion analysis. Journal of nuclear medicine: official publication. Soc. Nuclear Med. 60, 944\u2013949 (2019).","journal-title":"Soc. Nuclear Med."},{"key":"19283_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber, M. et al. Evaluation of hybrid \u2076\u2078Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy. Journal of nuclear medicine: official publication. Soc. Nuclear Med. 56, 668\u2013674 (2015).","journal-title":"Soc. Nuclear Med."},{"key":"19283_CR17","doi-asserted-by":"crossref","unstructured":"Epstein, J. I. et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. The American journal of surgical pathology 40:244\u2013252 (2016).","DOI":"10.1097\/PAS.0000000000000530"},{"key":"19283_CR18","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/modpathol.3800702","volume":"19","author":"CC Guo","year":"2006","unstructured":"Guo, C. C. & Epstein, J. I. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod. Pathol. 19, 1528\u20131535 (2006).","journal-title":"Mod. Pathol."},{"key":"19283_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/01.MP.0000038460.95912.6E","volume":"15","author":"MH Weinstein","year":"2002","unstructured":"Weinstein, M. H., Signoretti, S. & Loda, M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod. Pathology: Official J. United States Can. Acad. Pathol. Inc. 15, 1302\u20131308 (2002).","journal-title":"Mod. Pathology: Official J. United States Can. Acad. Pathol. Inc"},{"key":"19283_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00259-020-04934-4","volume":"48","author":"S Fanti","year":"2021","unstructured":"Fanti, S. et al. Consensus statements on PSMA PET\/CT response assessment criteria in prostate cancer. Eur. J. Nucl. Med. Mol. Imaging. 48, 469\u2013476 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"19283_CR21","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00259-019-04320-9","volume":"46","author":"J Gao","year":"2019","unstructured":"Gao, J. et al. Diagnostic performance of (68)Ga-PSMA PET\/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections. Eur. J. Nucl. Med. Mol. Imaging. 46, 1531\u20131541 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"19283_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","volume":"82","author":"GJ Netto","year":"2022","unstructured":"Netto, G. J. et al. The 2022 world health organization classification of tumors of the urinary system and male genital Organs-Part B: prostate and urinary tract tumors. Eur. Urol. 82, 469\u2013482 (2022).","journal-title":"Eur. Urol."},{"key":"19283_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/1097-0045(20000901)44:4<265::AID-PROS1>3.0.CO;2-I","volume":"44","author":"HJ Dawkins","year":"2000","unstructured":"Dawkins, H. J. et al. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate 44, 265\u2013270 (2000).","journal-title":"Prostate"},{"key":"19283_CR24","first-page":"6357","volume":"9","author":"JS Ross","year":"2003","unstructured":"Ross, J. S. et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin. Cancer Research: Official J. Am. Association Cancer Res. 9, 6357\u20136362 (2003).","journal-title":"Clin. Cancer Research: Official J. Am. Association Cancer Res."},{"key":"19283_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3389\/fonc.2018.00623","volume":"8","author":"MC Hupe","year":"2018","unstructured":"Hupe, M. C. et al. Expression of prostate-Specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis. Front. Oncol. 8, 623 (2018).","journal-title":"Front. Oncol."},{"key":"19283_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.humpath.2006.11.012","volume":"38","author":"S Perner","year":"2007","unstructured":"Perner, S. et al. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum. Pathol. 38, 696\u2013701 (2007).","journal-title":"Hum. Pathol."},{"key":"19283_CR27","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1007\/s00259-021-05501-1","volume":"48","author":"JH R\u00fcschoff","year":"2021","unstructured":"R\u00fcschoff, J. H. et al. What\u2019s behind (68)Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns. Eur. J. Nucl. Med. Mol. Imaging. 48, 4042\u20134053 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"19283_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.euo.2018.03.013","volume":"1","author":"R Montironi","year":"2018","unstructured":"Montironi, R., Zhou, M., Magi-Galluzzi, C. & Epstein, J. I. Features and prognostic significance of intraductal carcinoma of the prostate. Eur. Urol. Oncol. 1, 21\u201328 (2018).","journal-title":"Eur. Urol. Oncol."},{"key":"19283_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/his.12198","volume":"63","author":"K Watts","year":"2013","unstructured":"Watts, K., Li, J., Magi-Galluzzi, C. & Zhou, M. Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study. Histopathology 63, 574\u2013579 (2013).","journal-title":"Histopathology"},{"key":"19283_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","volume":"17","author":"A Stabile","year":"2020","unstructured":"Stabile, A. et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat. Reviews Urol. 17, 41\u201361 (2020).","journal-title":"Nat. Reviews Urol."},{"key":"19283_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/pros.24291","volume":"82","author":"A Mikoshi","year":"2022","unstructured":"Mikoshi, A. et al. MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern. Prostate 82, 452\u2013463 (2022).","journal-title":"Prostate"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19283-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19283-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19283-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:36:18Z","timestamp":1760016978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19283-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19283"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19283-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest with respect to the research, authorship and publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"35326"}}